Grant: Discovery Grants Program - Individual
University of Toronto
$53,000.00
Biosensing for organ-on-a-chip platforms
EF 2019-20
Résumé
Recent advances in tissue engineering and microfluidics have enabled the creation of “organ-on-a-chip” platforms that mimic the functions of human organs and tissues better than conventional Petri dish-based cell culture systems. These technologies hold great promise for disease modeling, drug discovery, and as bioreactor test beds to develop engineered tissues. Despite their great potential, a persistent limitation of organ-on-a-chip and microfluidic cell culture platforms is that they rely on manual, off-chip analytical methods, which creates an analysis bottleneck and limits the value of these platforms. Integration of on-chip sensing could enable higher-throughput and higher-content analyses, real-time measurement of cell and tissue function, and even feedback control of dynamic culture microsystems. Strikingly, while there have been significant advances in incorporating biosensors into point-of-care microfluidic devices, biosensors have not been integrated into microtissue and organ-on-a-chip platforms largely because of the engineering challenges involved. ******Here, we propose a research program to directly address these limitations by leveraging our novel microfluidic and microtissues technologies to engineer organ-on-a-chip platforms with on-chip biosensing capabilities. To do so, we investigate fundamental aspects of biotransport and biosensing to enable biomolecule detection in dynamic microfluidic environments; develop sensitive on-chip strain sensors to measure cell contraction forces; and identify process control strategies to engineer mechanically robust tissues. This knowledge will be applied to generate novel organ-on-a-chip models for monitoring transport across the blood-brain-barrier; for measuring heart muscle contraction on-chip; and for optimizing protocols for mechanical stimulation of engineered tissues.******The graduate and undergraduate students trained in this research program will be equipped with the scientific and professional skills required to apply the knowledge generated by their research for long-term impact and to lead bold new initiatives in biosensing, biomicrofluidics, and biotechnology in the future.**
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2016-06026
Name nom
Simmons, Craig
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2016
Award amount
53000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:4 - 5
Partie
4
Nb partie
5
Application title
Biosensing for organ-on-a-chip platforms
Keyword
NSERC
Application summary
Recent advances in tissue engineering and microfluidics have enabled the creation of “organ-on-a-chip” platforms that mimic the functions of human organs and tissues better than conventional Petri dish-based cell culture systems. These technologies hold great promise for disease modeling, drug discovery, and as bioreactor test beds to develop engineered tissues. Despite their great potential, a persistent limitation of organ-on-a-chip and microfluidic cell culture platforms is that they rely on manual, off-chip analytical methods, which creates an analysis bottleneck and limits the value of these platforms. Integration of on-chip sensing could enable higher-throughput and higher-content analyses, real-time measurement of cell and tissue function, and even feedback control of dynamic culture microsystems. Strikingly, while there have been significant advances in incorporating biosensors into point-of-care microfluidic devices, biosensors have not been integrated into microtissue and organ-on-a-chip platforms largely because of the engineering challenges involved. ******Here, we propose a research program to directly address these limitations by leveraging our novel microfluidic and microtissues technologies to engineer organ-on-a-chip platforms with on-chip biosensing capabilities. To do so, we investigate fundamental aspects of biotransport and biosensing to enable biomolecule detection in dynamic microfluidic environments; develop sensitive on-chip strain sensors to measure cell contraction forces; and identify process control strategies to engineer mechanically robust tissues. This knowledge will be applied to generate novel organ-on-a-chip models for monitoring transport across the blood-brain-barrier; for measuring heart muscle contraction on-chip; and for optimizing protocols for mechanical stimulation of engineered tissues.******The graduate and undergraduate students trained in this research program will be equipped with the scientific and professional skills required to apply the knowledge generated by their research for long-term impact and to lead bold new initiatives in biosensing, biomicrofluidics, and biotechnology in the future.**